Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Cardiac Progenitor Cell Therapy in Patients With Single Ventricle Physiology

NCT01273857 is registered in ClinicalTrials.gov with Okayama University as lead sponsor.

NCT NCT01273857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01273857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Cardiac Progenitor Cell Therapy in Patients With Single Ventricle Physiology
Lead sponsor
Okayama University
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
January 31, 2013
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, hypoplastic left heart syndrome, single ventricle